Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia | Zendy

Giulia Vicari | Zendy; Seth R. Bauer | Zendy; Elizabeth Neuner | Zendy; Simon W. Lam | Zendy

Open Access

Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia

Author(s) -

Giulia Vicari,

Seth R. Bauer,

Elizabeth Neuner,

Simon W. Lam

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis909

Subject(s) - medicine , bacteremia , colistin , gram negative bacterial infections , gram , multiple drug resistance , gram negative bacteria , microbiology and biotechnology , drug resistance , antibiotics , bacteria , genetics , biology , escherichia coli , gene

Colistin is increasingly used for the treatment of multidrug-resistant gram-negative infections. However, colistin dosing varies greatly and the optimal regimen is unknown. The purpose of this study was to determine if colistin dosing correlates with patient outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research